Pluristem Therapeutics In Shareholder Letter Says Recent Financing Provides Funding Through Multiple Potentially Value-Creating Milestones; Co. Short And Mid-Term Milestones, Targeting Marketing And Significant Contracts
Benzinga Newsdesk